Margel D - Search Results

1

Role of Metabolic Syndrome in Prostate Cancer Development.

Lifshitz K, Ber Y, Margel D. Lifshitz K, et al. Among authors: margel d. Eur Urol Focus. 2021 May;7(3):508-512. doi: 10.1016/j.euf.2021.04.022. Epub 2021 May 11. Eur Urol Focus. 2021. PMID: 33994167 Review.

2

Early initiation of aspirin after prostate and transurethral bladder surgeries is not associated with increased incidence of postoperative bleeding: a prospective, randomized trial.

Ehrlich Y, Yossepowitch O, Margel D, Lask D, Livne PM, Baniel J. Ehrlich Y, et al. Among authors: margel d. J Urol. 2007 Aug;178(2):524-8; discussion 528. doi: 10.1016/j.juro.2007.03.134. Epub 2007 Jun 14. J Urol. 2007. PMID: 17570430 Clinical Trial.

3

Diminished efficacy of Bacille Calmette-Guérin among elderly patients with nonmuscle invasive bladder cancer.

Margel D, Alkhateeb SS, Finelli A, Fleshner N. Margel D, et al. Urology. 2011 Oct;78(4):848-54. doi: 10.1016/j.urology.2011.04.070. Epub 2011 Aug 16. Urology. 2011. PMID: 21840578

4

Impact of multiparametric endorectal coil prostate magnetic resonance imaging on disease reclassification among active surveillance candidates: a prospective cohort study.

Margel D, Yap SA, Lawrentschuk N, Klotz L, Haider M, Hersey K, Finelli A, Zlotta A, Trachtenberg J, Fleshner N. Margel D, et al. J Urol. 2012 Apr;187(4):1247-52. doi: 10.1016/j.juro.2011.11.112. Epub 2012 Feb 14. J Urol. 2012. PMID: 22335871

5

Predictors of pathological progression among men with localized prostate cancer undergoing active surveillance: a sub-analysis of the REDEEM study.

Margel D, Nandy I, Wilson TH, Castro R, Fleshner N. Margel D, et al. J Urol. 2013 Dec;190(6):2039-45. doi: 10.1016/j.juro.2013.06.051. Epub 2013 Jun 29. J Urol. 2013. PMID: 23820059 Clinical Trial.

6

Association between metformin use and risk of prostate cancer and its grade.

Margel D, Urbach D, Lipscombe LL, Bell CM, Kulkarni G, Austin PC, Fleshner N. Margel D, et al. J Natl Cancer Inst. 2013 Aug 7;105(15):1123-31. doi: 10.1093/jnci/djt170. Epub 2013 Jul 13. J Natl Cancer Inst. 2013. PMID: 23853056

7

Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes.

Margel D, Urbach DR, Lipscombe LL, Bell CM, Kulkarni G, Austin PC, Fleshner N. Margel D, et al. J Clin Oncol. 2013 Sep 1;31(25):3069-75. doi: 10.1200/JCO.2012.46.7043. Epub 2013 Aug 5. J Clin Oncol. 2013. PMID: 23918942

8

Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort.

Bhindi B, Locke J, Alibhai SMH, Kulkarni GS, Margel DS, Hamilton RJ, Finelli A, Trachtenberg J, Zlotta AR, Toi A, Hersey KM, Evans A, van der Kwast TH, Fleshner NE. Bhindi B, et al. Eur Urol. 2015 Jan;67(1):64-70. doi: 10.1016/j.eururo.2014.01.040. Epub 2014 Feb 14. Eur Urol. 2015. PMID: 24568896

9

Metformin to prevent prostate cancer: a call to unite.

Margel D. Margel D. Eur Urol. 2014 Dec;66(6):1021-2. doi: 10.1016/j.eururo.2014.05.012. Epub 2014 Jun 5. Eur Urol. 2014. PMID: 24908475 No abstract available.

10

The impact of the use of aspirin and other nonsteroidal anti-inflammatory drugs on the risk of prostate cancer detection on biopsy.

Bhindi B, Margel D, Hamilton RJ, Fernandes KA, Trottier G, Hersey KM, Finelli A, Trachtenberg J, Zlotta A, Kulkarni GS, Toi A, Evans A, van der Kwast TH, Fleshner NE. Bhindi B, et al. Among authors: margel d. Urology. 2014 Nov;84(5):1073-80. doi: 10.1016/j.urology.2014.05.071. Epub 2014 Oct 24. Urology. 2014. PMID: 25443907

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

114 results

Search Page